Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults

NCT01381562 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01381562
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01381562 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess the Safety, Tolerability and Preliminary Efficacy of GSK2251052 in the Treatment of Complicated Intra-abdominal Infection in Adults
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
October 3, 2011
Completion date
March 5, 2012
Enrollment
15 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

infections, intestinal